Alan Fuhrman Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Alan Fuhrman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Alan Fuhrman. Alan Fuhrman is Senior Vice President & CFO in ONCOGENEX PHARMACEUTICALS, INC. ($OGXI) and Director in Esperion Therapeutics, Inc. ($ESPR) and Chief Financial Officer in Mirna Therapeutics, Inc. ($MIRN) and Director in Loxo Oncology, Inc. ($LOXO) and Director in SpringWorks Therapeutics, Inc. ($SWTX).
Latest Insider Trading Transactions of Alan Fuhrman
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACHV, ESPR, LOXO, SWTX, SYBX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 29 2020 | ESPR | Esperion Therapeut ... | Fuhrman Alan | Director | Grant | A | 0.00 | 1,221 | 0 | 12,878 | 11.7 K to 12.9 K (+10.47 %) |
| May 22 2020 | SWTX | SpringWorks Therap ... | Fuhrman Alan | Director | Option Exercise | A | 38.03 | 7,464 | 283,856 | 7,464 | |
| May 18 2020 | ESPR | Esperion Therapeut ... | Fuhrman Alan | Director | Grant | A | 0.00 | 11,003 | 0 | 11,657 | 654 to 11.7 K (+1,682.42 %) |
| Sep 16 2019 | SWTX | SpringWorks Therap ... | Fuhrman Alan | Director | Option Exercise | A | 18.00 | 29,983 | 539,694 | 29,983 | |
| Sep 16 2019 | SWTX | SpringWorks Therap ... | Fuhrman Alan | Director | Option Exercise | A | 18.00 | 29,983 | 539,694 | 29,983 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Fuhrman Alan | Director | Option Exercise | D | 180.98 | 8,750 | 1,583,575 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Fuhrman Alan | Director | Option Exercise | D | 78.58 | 11,000 | 864,380 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Fuhrman Alan | Director | Option Exercise | D | 24.18 | 7,812 | 188,894 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Fuhrman Alan | Director | Option Exercise | D | 20.91 | 7,812 | 163,349 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Fuhrman Alan | Director | Option Exercise | D | 11.35 | 13,000 | 147,550 | 0 | |
| Jun 14 2018 | LOXO | Loxo Oncology, Inc ... | Fuhrman Alan | Director | Option Exercise | A | 180.98 | 8,750 | 1,583,575 | 8,750 | |
| Jun 11 2018 | LOXO | Loxo Oncology, Inc ... | Fuhrman Alan | Director | Option Exercise | M | 11.35 | 2,625 | 29,794 | 13,000 | |
| Jun 11 2018 | LOXO | Loxo Oncology, Inc ... | Fuhrman Alan | Director | Sell | S | 178.07 | 2,625 | 467,437 | 0 | 2.6 K to 0 (-100.00 %) |
| Jun 11 2018 | LOXO | Loxo Oncology, Inc ... | Fuhrman Alan | Director | Buy | M | 11.35 | 2,625 | 29,794 | 2,625 | 0 to 2.6 K |
| Jun 23 2017 | LOXO | Loxo Oncology, Inc ... | Fuhrman Alan | Director | Option Exercise | A | 78.58 | 11,000 | 864,380 | 11,000 | |
| Jun 13 2016 | LOXO | Loxo Oncology, Inc ... | Fuhrman Alan | Director | Option Exercise | A | 24.18 | 7,812 | 188,894 | 7,812 | |
| Mar 14 2016 | MIRN | Mirna Therapeutics ... | Fuhrman Alan | Chief Financial Off ... | Option Exercise | A | 4.36 | 60,000 | 261,600 | 60,000 | |
| Sep 30 2015 | MIRN | Mirna Therapeutics ... | Fuhrman Alan | Chief Financial Off ... | Option Exercise | A | 7.00 | 167,180 | 1,170,260 | 167,180 | |
| Jul 30 2015 | LOXO | Loxo Oncology, Inc ... | Fuhrman Alan | Director | Option Exercise | A | 20.91 | 7,812 | 163,349 | 7,812 | |
| Jan 03 2007 | OGXI | ONCOGENEX PHARMACE ... | Fuhrman Alan | Senior Vice Preside ... | Option Exercise | A | 6.11 | 60,000 | 366,600 | 60,000 | |
| Jan 09 2006 | OGXI | ONCOGENEX PHARMACE ... | Fuhrman Alan | Senior Vice Preside ... | Option Exercise | A | 5.10 | 78,000 | 397,800 | 78,000 | |
| Sep 17 2004 | OGXI | ONCOGENEX PHARMACE ... | Fuhrman Alan | Senior Vice Preside ... | Option Exercise | A | 3.23 | 110,000 | 355,300 | 110,000 |
Page: 1